Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aberrant human leucocyte antigen‐G expression and its clinical relevance in hepatocellular carcinoma
Aifen Lin, H.‐X. Chen, Chengsong Zhu, et al.
Journal of Cellular and Molecular Medicine (2009) Vol. 14, Iss. 8, pp. 2162-2171
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

HLA-G
Edgardo D. Carosella, Nathalie Rouas‐Freiss, Diana Tronik‐Le Roux, et al.
Advances in immunology (2015), pp. 33-144
Closed Access | Times Cited: 341
NK Cell-Based Immune Checkpoint Inhibition
Muhammad Khan, Sumbal Arooj, Hua Wang
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 274
Unconventional T Cell Targets for Cancer Immunotherapy
Dale I. Godfrey, Jérôme Le Nours, Daniel M. Andrews, et al.
Immunity (2018) Vol. 48, Iss. 3, pp. 453-473
Open Access | Times Cited: 272
Diversity of immune checkpoints in cancer immunotherapy
Zhangyan Guo, Rui Zhang, Angang Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 44
The immunosuppressive molecule HLA-G and its clinical implications
Álvaro González, Vera Rebmann, Joël LeMaoult, et al.
Critical Reviews in Clinical Laboratory Sciences (2012) Vol. 49, Iss. 3, pp. 63-84
Closed Access | Times Cited: 190
Hypoxia-inducible factors and innate immunity in liver cancer
Vincent Wai‐Hin Yuen, Carmen Chak‐Lui Wong
Journal of Clinical Investigation (2020) Vol. 130, Iss. 10, pp. 5052-5062
Open Access | Times Cited: 136
Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges
Aifen Lin, Wei‐Hua Yan
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 121
Human Leukocyte Antigen-G (HLA-G) Expression in Cancers: Roles in Immune Evasion, Metastasis and Target for Therapy
Aifen Lin, Wei‐Hua Yan
Molecular Medicine (2015) Vol. 21, Iss. 1, pp. 782-791
Open Access | Times Cited: 120
Harnessing the immune system against cancer: current immunotherapy approaches and therapeutic targets
Ayana R. Kumar, Aswathy R. Devan, Bhagyalakshmi Nair, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 12, pp. 8075-8095
Open Access | Times Cited: 86
Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects
Siyuan Wang, Jiaxin Wang, Yu Xia, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
The Role of HLA-G Molecule and HLA-G Gene Polymorphisms in Tumors, Viral Hepatitis, and Parasitic Diseases
Fabrício C. Dias, Erick C. Castelli, Cristhianna V. A. Collares, et al.
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 71
Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis
Emilia Andersson, Isabel Poschke, Lisa Villabona, et al.
OncoImmunology (2015) Vol. 5, Iss. 1, pp. e1052213-e1052213
Open Access | Times Cited: 66
HLA-G: A New Immune Checkpoint in Cancer?
Daniëlle Krijgsman, Jessica Roelands, Wouter Hendrickx, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4528-4528
Open Access | Times Cited: 66
HLA-G Neo-Expression on Tumors
Maria Loustau, François Anna, Raphaelle Dréan, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 58
HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges
Aifen Lin, Wei‐Hua Yan
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 45
HLA-G and Other Immune Checkpoint Molecules as Targets for Novel Combined Immunotherapies
Fabio Morandi, Irma Airoldi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 2925-2925
Open Access | Times Cited: 30
Human leukocyte antigen‐G is closely associated with tumor immune escape in gastric cancer by increasing local regulatory T cells
Lutao Du, Xiaoyan Xiao, Chuanxin Wang, et al.
Cancer Science (2011) Vol. 102, Iss. 7, pp. 1272-1280
Open Access | Times Cited: 76
Human leukocyte antigen-G (HLA-G) expression in cervical cancer lesions is associated with disease progression
Xiang-Juan Li, Xia Zhang, Aifen Lin, et al.
Human Immunology (2012) Vol. 73, Iss. 9, pp. 946-949
Closed Access | Times Cited: 66
The Potential of HLA-G-Bearing Extracellular Vesicles as a Future Element in HLA-G Immune Biology
Vera Rebmann, Lisa König, Fabiola da Silva Nardi, et al.
Frontiers in Immunology (2016) Vol. 7
Open Access | Times Cited: 58
Biology of the immunomodulatory molecule HLA-G in human liver diseases
Laurence Amiot, Nicolas Vu, Michel Samson
Journal of Hepatology (2015) Vol. 62, Iss. 6, pp. 1430-1437
Open Access | Times Cited: 57
The Molecular and Functional Characteristics of HLA-G and the Interaction with Its Receptors: Where to Intervene for Cancer Immunotherapy?
Jiji V. D. Attia, Charlotte E. Dessens, Ricky B. van de Water, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8678-8678
Open Access | Times Cited: 40
Fibrosis and Hepatocarcinogenesis: Role of Gene-Environment Interactions in Liver Disease Progression
Anindita Banerjee, Patrizia Farci
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8641-8641
Open Access | Times Cited: 4
Human leukocyte antigen‐G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma
Aifen Lin, Xia Zhang, Wenjun Zhou, et al.
International Journal of Cancer (2010) Vol. 129, Iss. 6, pp. 1382-1390
Open Access | Times Cited: 58
Human leukocyte antigen-G in cancer: Are they clinically relevant?
Wei‐Hua Yan
Cancer Letters (2011) Vol. 311, Iss. 2, pp. 123-130
Closed Access | Times Cited: 58
Association ofHLA-G3′ UTR 14-bp Insertion/Deletion Polymorphism with Hepatocellular Carcinoma Susceptibility in a Chinese Population
Yuting Jiang, Shougong Chen, Shasha Jia, et al.
DNA and Cell Biology (2011) Vol. 30, Iss. 12, pp. 1027-1032
Closed Access | Times Cited: 56
Page 1 - Next Page

Scroll to top